Intelligence · Clinical Development
Pipeline search results
Programs matching “ramelteon” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 31 pipeline programs matching "ramelteon" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Ramelteon
Takeda
Sleep Initiation and Maintenance Disorders
2 trials -
Ramelteon
Takeda
Transient Insomnia
1 trial -
Ramelteon
Takeda
Balance
1 trial -
Ramelteon SL
Takeda
Bipolar Disorder
1 trial -
Ramelteon SL
Takeda
Acute Depressive Episode
1 trial -
Ramelteon SL (Dose 1)
Takeda
Bipolar Disorder
1 trial -
Ramelteon and Placebo (9 possible combinations total)
Takeda
Chronic Insomnia
1 trial -
01-02-TL-375-015
Takeda
Drug Abuse
1 trial -
Ramelteon
Takeda
Migraine
1 trial -
Ramelteon
Takeda
Sleep Disorders, Circadian Rhythm
1 trial -
Ramelteon
Takeda
Sleep Disorder
1 trial -
Ramelteon
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Ramelteon and Placebo (25 possible combinations total)
Takeda
Chronic Insomnia
1 trial -
Ramelteon and doxepin
Takeda
Sleep Initiation and Maintenance Disorders
1 trial -
Ramelteon and gabapentin
Takeda
Sleep Initiation and Maintenance Disorders
1 trial -
Ramelteon or Placebo
Takeda
Sleep Apnea, Obstructive
1 trial -
Ramelteon 8 mg
Takeda
Insomnia
1 trial -
Ramelteon
Takeda
Circadian Dysregulation
1 trial -
Ramelteon
Takeda
Insomnia
6 trials -
Ramelteon
Takeda
Schizophrenia
1 trial -
Ramelteon
Takeda
Seasonal Affective Disorder
1 trial -
Ramelteon
Takeda
Chronic Insomnia
7 trials -
Ramelteon
Takeda
Bipolar Disorder
2 trials -
Ramelteon
Takeda
ADHD With Sleep Onset Insomnia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.